Practice question

Answer the question and get instant feedback.

Moderateeven with preserved to moderately reduced eGFRChronic Kidney Disease"kdigo guideline (2024): ckd evaluation and management"

A 62-year-old with stage 3 CKD (eGFR 48 mL/min/1.73 m²) and UACR 220 mg/g has hypertension. According to KDIGO 2024, which therapy is indicated to slow kidney disease progression?

Educational content. Not a substitute for clinical judgement or local policy.